7,8-Dihydroxy-4-phenylcoumarin

CAS No. 842-01-3

7,8-Dihydroxy-4-phenylcoumarin( —— )

Catalog No. M19166 CAS No. 842-01-3

7,8-Dihydroxy-4-phenylcoumarin inhibits the activity of Staphylococcus aureus DNA helicase

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7,8-Dihydroxy-4-phenylcoumarin
  • Note
    Research use only, not for human use.
  • Brief Description
    7,8-Dihydroxy-4-phenylcoumarin inhibits the activity of Staphylococcus aureus DNA helicase
  • Description
    7,8-Dihydroxy-4-phenylcoumarin inhibits the activity of Staphylococcus aureus DNA helicase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    842-01-3
  • Formula Weight
    254.24
  • Molecular Formula
    C15H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (393.33 mM)
  • SMILES
    C1=CC=C(C=C1)C2=CC(=O)OC3=C2C=CC(=C3O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ML-335

    ML-335 is a μ-δ isomer-targeted agonist, a μOR-δOR-biased ligand that can serve as a scaffold for the development of unique types of (isomer-biased) drugs.

  • 6-GNTI dihydrochlori...

    6'-GNTI dihydrochloride is a κ-opioid receptor (KOR) agonist that favors activation of G-protein-mediated signaling over recruitment of β-aspirin 2. 6'-GNTI dihydrochloride only activates the Akt pathway in striatal neurons.

  • Cannabidiol

    Cannabidiol is GPR55 and weak CB1 antagonist (IC50s: 0.445 and 3.35 μM) CB2 receptor inverse agonist and inhibitor of anandamide uptake (IC50: 27.5 μM). It also a weak agonist at VR1 vanilloid receptors (EC50: 3.5 μM).